Ultragenyx Pharmaceutical Inc. ($RARE)
Filing Information
| Accession Number | 0001193125-26-100309 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,526
Total Value
$208,311.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP and Chief Legal Officer | Common Stock | โ | Mar 6, 2026 | Sale | 6,018 | $21.40 | $128,785.20 | 70,328 | Direct | โ | View Details | |
EVP and Chief Legal Officer | Common Stock | โ | Mar 10, 2026 | Sale | 3,508 | $22.67 | $79,526.36 | 66,820 | Direct | โ | View Details |